Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can artery clearing for blocked legs be done without an overnight stay?

NCT ID NCT02581150

Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are comparing two ways to treat blocked leg arteries: doing the procedure as an outpatient visit versus keeping patients overnight in the hospital. The study enrolls 160 adults with peripheral arterial disease who need a minimally invasive procedure to open their arteries. The team tracks costs and quality of life for three months to see which approach gives better value for the money.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
endovascular treatment of blocked leg arteries, performed as an outpatient procedure or with an overnight hospital stay
What this could lead to
If outpatient treatment proves as effective and cheaper, more patients with blocked leg arteries could avoid overnight hospital stays.
What could go wrong
This is a small study in one health system, so its cost findings may not apply elsewhere. Outpatient artery procedures carry a small risk of bleeding or complications that need hospital care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

160 people

The number who actually took part.

Start date

Feb 2016

Finished

Aug 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients limping * Patients with PAD requiring endovascular management * Patients with stabilized level 1 to 3 ASA (classification of the American Society of Anesthesiology) * Ability to walking * Endovascular indicated and compatible with an introducer 5F to 7F * Agreeing to participate in the study and having signed an informed consent. * Agreeing to lend itself to a post-operative monitoring a duration of 30 days * Social Insured Exclusion Criteria: * No possibility of an outpatient management * Previous participation in the AMBUVASC study * Refusal of patient to participate in the study * Patient with hemostasis disorders * Acute Ischemia * Using a more 7F introducer * Radial or brachial puncture * Antegrade femoral puncture * Contraindication to endovascular treatment * Less than one month life expectancy * Participation in another clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral arterial disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peripheral arterial disease

Contacts and locations

Locations

  • Besançon University Hospital

    Besançon, France

  • Clinique de Fontaine

    Fontaine-lès-Dijon, France

  • Colmar Hospital

    Colmar, France

  • Dijon University Hospital

    Dijon, France

  • La Roche sur Yon Hospital

    La Roche-sur-Yon, France

  • Marseille University Hospital (La Timone)

    Marseille, France

  • Marseille University Hospital (North)

    Marseille, France

  • Nantes University Hospital

    Nantes, France

  • Rennes University Hospital

    Rennes, France

  • Rouen Clinique de l'Europe

    Rouen, France

  • Saint-Etienne University Hospital

    Saint-Etienne, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.